Assess whether related-party sales should be backed out of valuation (88fa00)

SITUATION In a health-system acquiring a specialty practice, management-team retention and key-person map is the evidence after a customer who just sent a non-renewal. Buy-side QoE lead has to pick Proceed or Reprice for this M&A Due Diligence Legal, IP, and Regulatory close using management-team retention and key-person map.

DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using management-team retention and key-person map after a customer who just sent a non-renewal.

HYPOTHESES TO TEST 1. A customer who just sent a non-renewal is noise around an already-controlled Legal, IP, and Regulatory process in a health-system acquiring a specialty practice, given management-team retention and key-person map. 2. A customer who just sent a non-renewal is the event in management-team retention and key-person map that forces Proceed for buy-side QoE lead under M&A Due Diligence. 3. Management-team retention and key-person map shows a one-file miss after a customer who just sent a non-renewal, not a Legal, IP, and Regulatory program failure. 4. Management-team retention and key-person map cannot decide related-party sales should be yet after a customer who just sent a non-renewal; hold is the only M&A Due Diligence close a health-system acquiring a specialty practice can defend.

ANALYSIS REQUIRED 1. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 2. Tie quality-of-earnings, working-capital, and contingent items in management-team retention and key-person map to related-party sales should be. 3. Name the document buy-side QoE lead still needs before signing. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read management-team retention and key-person map against a customer who just sent a non-renewal and write the one fact that would move related-party sales should be for buy-side QoE lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (management-team retention and key-person map after a customer who just sent a non-renewal). Lead with the M&A Due Diligence option management-team retention and key-person map can support after a customer who just sent a non-renewal, then the two facts that force it, then the Monday action for buy-side QoE lead in a health-system acquiring a specialty practice.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in management-team retention and key-person map, then the action for buy-side QoE lead - Hypothesis scorecard against management-team retention and key-person map: supported / rejected / untestable - Missing page in management-team retention and key-person map after a customer who just sent a non-renewal, if any - Regulatory or exam hook Legal, IP, and Regulatory would cite